Company intelligence / Profile preview

Eight Advisory

Ownership: Private
Employees: ~1100
Development stage: Other

Overview

Eight Advisory is a European consulting firm specializing in financial, operational, and strategic advisory services. The company supports clients with transactions (including M&A), restructuring, transformation projects, and related services. While it has sector expertise in healthcare and has advised on deals involving life sciences companies (such as Nutrisens and Ypsomed AG), it does not itself develop drugs or medical products[1][2][5]. Its core business remains consulting rather than biotech/pharma R&D.

Industry: Consulting

Partnerships

No major pharmaceutical or biotech partnerships; works with private equity firms and corporates across sectors[2].

Beyond the preview

Go deeper on Eight Advisory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eight Advisory.

Explore the full profile